Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Temodex (temozolomide gel)
i
Other names:
SI 053
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(7)
News
Trials
Company:
Belmedpreparaty, Double Bond Pharmaceutical
Drug class:
DNA synthesis inhibitor, Alkylating agent
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
mitomycin (3)
bendamustine RTD (2)
LP-284 (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
PR104 (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
mitomycin (3)
bendamustine RTD (2)
LP-284 (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
TL-118 (0)
altretamine (0)
mechlorethamine (0)
PR104 (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
›
Associations
(7)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Astrocytoma
No biomarker
Astrocytoma
temozolomide gel
Sensitive: A2 - Guideline
temozolomide gel
Sensitive
:
A2
temozolomide gel
Sensitive: A2 - Guideline
temozolomide gel
Sensitive
:
A2
IDH1 mutation
Glioma
IDH1 mutation
Glioma
temozolomide gel
Sensitive: B - Late Trials
temozolomide gel
Sensitive
:
B
temozolomide gel
Sensitive: B - Late Trials
temozolomide gel
Sensitive
:
B
IDH2 mutation
Glioma
IDH2 mutation
Glioma
temozolomide gel
Sensitive: B - Late Trials
temozolomide gel
Sensitive
:
B
temozolomide gel
Sensitive: B - Late Trials
temozolomide gel
Sensitive
:
B
IDH2 mutation
Glioblastoma
IDH2 mutation
Glioblastoma
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
TP53 mutation
Glioma
TP53 mutation
Glioma
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
SETD2 mutation + MGMT promoter methylation
Glioblastoma
SETD2 mutation + MGMT promoter methylation
Glioblastoma
temozolomide gel
Resistant: C3 – Early Trials
temozolomide gel
Resistant
:
C3
temozolomide gel
Resistant: C3 – Early Trials
temozolomide gel
Resistant
:
C3
PIK3CA mutation + TTN mutation + IDH2 mutation
Glioma
PIK3CA mutation + TTN mutation + IDH2 mutation
Glioma
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
temozolomide gel
Sensitive: C3 – Early Trials
temozolomide gel
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login